- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this latest study, the 2020 growth of Celecoxib will have significant change from previous year. By the most conservative estimates of global Celecoxib market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1110.3 million in 2019. Over the next five years the Celecoxib market will register a 8.7% CAGR in terms of revenue, the global market size will reach US$ 1548.5 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Celecoxib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
50mg
100mg
200mg
400mg
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Celecoxib Consumption 2016-2026
2.1.2 Celecoxib Consumption CAGR by Region
2.2 Celecoxib Segment by Type
2.2.1 50mg
2.2.2 100mg
2.2.3 200mg
2.2.4 400mg
2.3 Celecoxib Sales by Type
2.3.1 Global Celecoxib Sales Market Share by Type (2016-2021)
2.3.2 Global Celecoxib Revenue and Market Share by Type (2016-2021)
2.3.3 Global Celecoxib Sale Price by Type (2016-2021)
2.4 Celecoxib Segment by Application
2.4.1 Rheumatoid arthritis
2.4.2 osteoarthritis
2.4.3 Acute pain
2.4.4 Musculoskeletal pain
2.4.5 Other diseases
2.5 Celecoxib Sales by Application
2.5.1 Global Celecoxib Sale Market Share by Application (2016-2021)
2.5.2 Global Celecoxib Revenue and Market Share by Application (2016-2021)
2.5.3 Global Celecoxib Sale Price by Application (2016-2021)
3 Global Celecoxib by Company
3.1 Global Celecoxib Sales Market Share by Company
3.1.1 Global Celecoxib Sales by Company (2019-2021)
3.1.2 Global Celecoxib Sales Market Share by Company (2019-2021)
3.2 Global Celecoxib Revenue Market Share by Company
3.2.1 Global Celecoxib Revenue by Company (2019-2021)
3.2.2 Global Celecoxib Revenue Market Share by Company (2019-2021)
3.3 Global Celecoxib Sale Price by Company
3.4 Global Manufacturers Celecoxib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Celecoxib Product Location Distribution
3.4.2 Players Celecoxib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Celecoxib by Region
4.1 Global Celecoxib by Region
4.1.1 Global Celecoxib Sales by Region
4.1.2 Global Celecoxib Revenue by Region
4.2 Americas Celecoxib Sales Growth
4.3 APAC Celecoxib Sales Growth
4.4 Europe Celecoxib Sales Growth
4.5 Middle East & Africa Celecoxib Sales Growth
5 Americas
5.1 Americas Celecoxib Sales by Country
5.1.1 Americas Celecoxib Sales by Country (2016-2021)
5.1.2 Americas Celecoxib Revenue by Country (2016-2021)
5.2 Americas Celecoxib Sales by Type
5.3 Americas Celecoxib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Celecoxib Sales by Region
6.1.1 APAC Celecoxib Sales by Region (2016-2021)
6.1.2 APAC Celecoxib Revenue by Region (2016-2021)
6.2 APAC Celecoxib Sales by Type
6.3 APAC Celecoxib Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Celecoxib by Country
7.1.1 Europe Celecoxib Sales by Country (2016-2021)
7.1.2 Europe Celecoxib Revenue by Country (2016-2021)
7.2 Europe Celecoxib Sales by Type
7.3 Europe Celecoxib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Celecoxib by Country
8.1.1 Middle East & Africa Celecoxib Sales by Country (2016-2021)
8.1.2 Middle East & Africa Celecoxib Revenue by Country (2016-2021)
8.2 Middle East & Africa Celecoxib Sales by Type
8.3 Middle East & Africa Celecoxib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Celecoxib Distributors
10.3 Celecoxib Customer
11 Global Celecoxib Market Forecast
11.1 Global Celecoxib Forecast by Region
11.1.1 Global Celecoxib Forecast by Regions (2021-2026)
11.2.2 Global Celecoxib Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Celecoxib Forecast by Type
11.7 Global Celecoxib Forecast by Application
12 Key Players Analysis
12.1 Pfizer Inc
12.1.1 Pfizer Inc Pfizer Inc Company Information
12.1.2 Pfizer Inc Celecoxib Product Offered
12.1.3 Pfizer Inc Celecoxib Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pfizer Inc Main Business Overview
12.1.5 Pfizer Inc Latest Developments
12.2 Teva
12.2.1 Teva Company Information
12.2.2 Teva Celecoxib Product Offered
12.2.3 Teva Celecoxib Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Teva Main Business Overview
12.2.5 Teva Latest Developments
12.3 Mylan
12.3.1 Mylan Company Information
12.3.2 Mylan Celecoxib Product Offered
12.3.3 Mylan Celecoxib Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Mylan Main Business Overview
12.3.5 Mylan Latest Developments
12.4 Apotex
12.4.1 Apotex Company Information
12.4.2 Apotex Celecoxib Product Offered
12.4.3 Apotex Celecoxib Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Apotex Main Business Overview
12.4.5 Apotex Latest Developments
12.5 Lupin
12.5.1 Lupin Company Information
12.5.2 Lupin Celecoxib Product Offered
12.5.3 Lupin Celecoxib Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Lupin Main Business Overview
12.5.5 Lupin Latest Developments
12.6 Hengrui Medicine
12.6.1 Hengrui Medicine Company Information
12.6.2 Hengrui Medicine Celecoxib Product Offered
12.6.3 Hengrui Medicine Celecoxib Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Hengrui Medicine Main Business Overview
12.6.5 Hengrui Medicine Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Celecoxib Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 50mg
Table 3. Major Players of 100mg
Table 4. Major Players of 200mg
Table 5. Major Players of 400mg
Table 6. Global Celecoxib Sales by Type (2016-2021) & (K Units)
Table 7. Global Celecoxib Sales Market Share by Type (2016-2021)
Table 8. Global Celecoxib Revenue by Type (2016-2021) & ($ million)
Table 9. Global Celecoxib Revenue Market Share by Type (2016-2021)
Table 10. Global Celecoxib Sale Price by Type (2016-2021)
Table 11. Global Celecoxib Sales by Application (2016-2021) & (K Units)
Table 12. Global Celecoxib Sales Market Share by Application (2016-2021)
Table 13. Global Celecoxib Value by Application (2016-2021)
Table 14. Global Celecoxib Revenue Market Share by Application (2016-2021)
Table 15. Global Celecoxib Sale Price by Application (2016-2021)
Table 16. Global Celecoxib Sales by Company (2019-2021) & (K Units)
Table 17. Global Celecoxib Sales Market Share by Company (2019-2021)
Table 18. Global Celecoxib Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Celecoxib Revenue Market Share by Company (2019-2021)
Table 20. Global Celecoxib Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Celecoxib Producing Area Distribution and Sales Area
Table 22. Players Celecoxib Products Offered
Table 23. Celecoxib Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Celecoxib Sales by Region (2016-2021) (K Units)
Table 27. Global Celecoxib Sales Market Share by Region (2016-2021)
Table 28. Global Celecoxib Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Celecoxib Revenue Market Share by Region (2016-2021)
Table 30. Americas Celecoxib Sales by Country (2016-2021) & (K Units)
Table 31. Americas Celecoxib Sales Market Share by Country (2016-2021)
Table 32. Americas Celecoxib Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Celecoxib Revenue Market Share by Country (2016-2021)
Table 34. Americas Celecoxib Sales by Type (2016-2021) & (K Units)
Table 35. Americas Celecoxib Sales Market Share by Type (2016-2021)
Table 36. Americas Celecoxib Sales by Application (2016-2021) & (K Units)
Table 37. Americas Celecoxib Sales Market Share by Application (2016-2021)
Table 38. APAC Celecoxib Sales by Region (2016-2021) & (K Units)
Table 39. APAC Celecoxib Sales Market Share by Region (2016-2021)
Table 40. APAC Celecoxib Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Celecoxib Revenue Market Share by Region (2016-2021)
Table 42. APAC Celecoxib Sales by Type (2016-2021) & (K Units)
Table 43. APAC Celecoxib Sales Market Share by Type (2016-2021)
Table 44. APAC Celecoxib Sales by Application (2016-2021) & (K Units)
Table 45. APAC Celecoxib Sales Market Share by Application (2016-2021)
Table 46. Europe Celecoxib Sales by Country (2016-2021) & (K Units)
Table 47. Europe Celecoxib Sales Market Share by Country (2016-2021)
Table 48. Europe Celecoxib Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Celecoxib Revenue Market Share by Country (2016-2021)
Table 50. Europe Celecoxib Sales by Type (2016-2021) & (K Units)
Table 51. Europe Celecoxib Sales Market Share by Type (2016-2021)
Table 52. Europe Celecoxib Sales by Application (2016-2021) & (K Units)
Table 53. Europe Celecoxib Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Celecoxib Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa Celecoxib Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Celecoxib Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Celecoxib Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Celecoxib Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa Celecoxib Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Celecoxib Sales by Application (2016-2021) & (K Units)
Table 61. Middle East & Africa Celecoxib Sales Market Share by Application (2016-2021)
Table 62. Global Celecoxib Sales Forecast by Type (2021-2026) & (K Units)
Table 63. Global Celecoxib Sales Market Share Forecast by Type (2021-2026)
Table 64. Global Celecoxib Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 65. Global Celecoxib Revenue Market Share Forecast by Type (2021-2026)
Table 66. Global Celecoxib Sales Forecast by Application (2021-2026) & (K Units)
Table 67. Global Celecoxib Sales Market Share Forecast by Application (2021-2026)
Table 68. Global Celecoxib Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 69. Global Celecoxib Revenue Market Share Forecast by Application (2021-2026)
Table 70. Pfizer Inc Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 71. Pfizer Inc Celecoxib Product Offered
Table 72. Pfizer Inc Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 73. Pfizer Inc Main Business
Table 74. Pfizer Inc Latest Developments
Table 75. Teva Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 76. Teva Celecoxib Product Offered
Table 77. Teva Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 78. Teva Main Business
Table 79. Teva Latest Developments
Table 80. Mylan Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 81. Mylan Celecoxib Product Offered
Table 82. Mylan Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 83. Mylan Main Business
Table 84. Mylan Latest Developments
Table 85. Apotex Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 86. Apotex Celecoxib Product Offered
Table 87. Apotex Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 88. Apotex Main Business
Table 89. Apotex Latest Developments
Table 90. Lupin Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 91. Lupin Celecoxib Product Offered
Table 92. Lupin Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 93. Lupin Main Business
Table 94. Lupin Latest Developments
Table 95. Hengrui Medicine Basic Information, Celecoxib Manufacturing Base, Sales Area and Its Competitors
Table 96. Hengrui Medicine Celecoxib Product Offered
Table 97. Hengrui Medicine Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 98. Hengrui Medicine Main Business
Table 99. Hengrui Medicine Latest Developments
List of Figures
Figure 1. Picture of Celecoxib
Figure 2. Celecoxib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Celecoxib Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Celecoxib Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Celecoxib Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 50mg
Figure 10. Product Picture of 100mg
Figure 11. Product Picture of 200mg
Figure 12. Product Picture of 400mg
Figure 13. Global Celecoxib Sales Market Share by Type in 2020
Figure 14. Global Celecoxib Revenue Market Share by Type (2016-2021)
Figure 15. Celecoxib Consumed in Rheumatoid arthritis
Figure 16. Global Celecoxib Market: Rheumatoid arthritis (2016-2021) & (K Units)
Figure 17. Celecoxib Consumed in osteoarthritis
Figure 18. Global Celecoxib Market: osteoarthritis (2016-2021) & (K Units)
Figure 19. Celecoxib Consumed in Acute pain
Figure 20. Global Celecoxib Market: Acute pain (2016-2021) & (K Units)
Figure 21. Celecoxib Consumed in Musculoskeletal pain
Figure 22. Global Celecoxib Market: Musculoskeletal pain (2016-2021) & (K Units)
Figure 23. Celecoxib Consumed in Other diseases
Figure 24. Global Celecoxib Market: Other diseases (2016-2021) & (K Units)
Figure 25. Global Celecoxib Sales Market Share by Application (2016-2021)
Figure 26. Global Celecoxib Revenue Market Share by Application in 2020
Figure 27. Global Celecoxib Revenue Market by Company in 2020 ($ Million)
Figure 28. Global Celecoxib Revenue Market Share by Company in 2020
Figure 29. Global Celecoxib Sales Market Share by Regions (2016-2021)
Figure 30. Global Celecoxib Revenue Market Share by Region in 2020
Figure 31. Americas Celecoxib Sales 2016-2021 (K Units)
Figure 32. Americas Celecoxib Revenue 2016-2021 ($ Millions)
Figure 33. APAC Celecoxib Sales 2016-2021 (K Units)
Figure 34. APAC Celecoxib Revenue 2016-2021 ($ Millions)
Figure 35. Europe Celecoxib Sales 2016-2021 (K Units)
Figure 36. Europe Celecoxib Revenue 2016-2021 ($ Millions)
Figure 37. Middle East & Africa Celecoxib Sales 2016-2021 (K Units)
Figure 38. Middle East & Africa Celecoxib Revenue 2016-2021 ($ Millions)
Figure 39. Americas Celecoxib Sales Market Share by Country in 2020
Figure 40. Americas Celecoxib Revenue Market Share by Country in 2020
Figure 41. Americas Celecoxib Sales Market Share by Type in 2020
Figure 42. Americas Celecoxib Sales Market Share by Application in 2020
Figure 43. United States Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 44. Canada Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 45. Mexico Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 46. Brazil Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 47. APAC Celecoxib Sales Market Share by Region in 2020
Figure 48. APAC Celecoxib Revenue Market Share by Regions in 2020
Figure 49. APAC Celecoxib Sales Market Share by Type in 2020
Figure 50. APAC Celecoxib Sales Market Share by Application in 2020
Figure 51. China Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 52. Japan Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 53. Korea Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 54. Southeast Asia Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 55. India Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 56. Australia Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 57. Europe Celecoxib Sales Market Share by Country in 2020
Figure 58. Europe Celecoxib Revenue Market Share by Country in 2020
Figure 59. Europe Celecoxib Sales Market Share by Type in 2020
Figure 60. Europe Celecoxib Sales Market Share by Application in 2020
Figure 61. Germany Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 62. France Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 63. UK Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 64. Italy Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 65. Russia Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 66. Middle East & Africa Celecoxib Sales Market Share by Country in 2020
Figure 67. Middle East & Africa Celecoxib Revenue Market Share by Country in 2020
Figure 68. Middle East & Africa Celecoxib Sales Market Share by Type in 2020
Figure 69. Middle East & Africa Celecoxib Sales Market Share by Application in 2020
Figure 70. Egypt Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 71. South Africa Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 72. Israel Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 73. Turkey Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 74. GCC Country Celecoxib Revenue Growth 2016-2021 ($ Millions)
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Please feel free to write an email to us or to use our electronic ticketing system.
